No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NVCR Novocure
- 16.800
- -0.550-3.17%
Close Jul 2 16:00 ET
- 17.000
- +0.200+1.19%
Post 19:11 ET
1.81BMarket Cap-9281P/E (TTM)
17.490High16.620Low1.28MVolume17.440Open17.350Pre Close21.64MTurnover1.31%Turnover RatioLossP/E (Static)107.61MShares42.69052wk High5.03P/B1.64BFloat Cap10.87052wk Low--Dividend TTM97.90MShs Float232.760Historical High--Div YieldTTM5.01%Amplitude5.950Historical Low16.860Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Breaking Down NovoCure: 4 Analysts Share Their Views
4 analysts have expressed a variety of opinions on NovoCure (NASDAQ:NVCR) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview
Novocure Is Maintained at In-Line by Evercore ISI Group
Novocure Is Maintained at In-Line by Evercore ISI Group
Evercore Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $20
Evercore analyst Vijay Kumar maintains $Novocure(NVCR.US)$ with a hold rating, and adjusts the target price from $14.5 to $20.According to TipRanks data, the analyst has a success rate of 47.4% and a
Novocure to Report Second Quarter 2024 Financial Results
ROOT, Switzerland–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial marke
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Comments
$Novocure(NVCR.US$ pt anyone?
2
$Novocure(NVCR.US$ I placed limit buy @13.1 but got filled at 13.299, I noticed this many times in this app, they are causing slippage, anyone noticed same?
1
$iBio Inc (IBIO.US)$ IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for obesity and cardiometabolic diseases.
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
Morning Movers
Gapping up
$Deutsche Bank(DB.US$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$Merck & Co(MRK.US$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$Trump Media & Technology(DJT.US$ stock jumped 14%, following gains after its Nasdaq debut.
$Robinhood(HOOD.US$ stock climbed 6...
Gapping up
$Deutsche Bank(DB.US$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$Merck & Co(MRK.US$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$Trump Media & Technology(DJT.US$ stock jumped 14%, following gains after its Nasdaq debut.
$Robinhood(HOOD.US$ stock climbed 6...
34
Key Takeaway
GameStop ( $GameStop(GME.US$ ) and Forge Global ( $Forge Global(FRGE.US$ ) face pre-market declines of 17% and 11% respectively, while Novocure ( $Novocure(NVCR.US$ ) surges 30% on positive trial results.
Merck ( $Merck & Co(MRK.US$ ) gains 4% after FDA approval of its treatment, highlighting a day of significant volatility and strategic moves in the U.S. stock market.
A Glimpse into Quarter-End Moves
As the curtains draw near on...
GameStop ( $GameStop(GME.US$ ) and Forge Global ( $Forge Global(FRGE.US$ ) face pre-market declines of 17% and 11% respectively, while Novocure ( $Novocure(NVCR.US$ ) surges 30% on positive trial results.
Merck ( $Merck & Co(MRK.US$ ) gains 4% after FDA approval of its treatment, highlighting a day of significant volatility and strategic moves in the U.S. stock market.
A Glimpse into Quarter-End Moves
As the curtains draw near on...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
灵巧的托拜厄斯 : having
Kenneil NugentOP : lol no help